A group of bipartisan senators introduced a plan to streamline the FDA’s regulation that would speed up the process of taking innovations to the market and encourage innovation. The bill would also focus on restoring balance to the conflict of interest...
The fourth annual Indiana CTSI meeting will be held May 7th 2012, at the University Place Conference Center and Hotel at IUPUI. The meeting will offer a platform to hear from researchers, view presentations and network with professionals. Save the date on your 2012...
The FDA is working on developing a quality-by-design (QbD) model for clinical trials that would cut monitoring costs. The plan is to implement the model within the next 25 years. There is already a QbD model is place for manufacturing that allows for the quality...
Recently at a conference held by the Institute of Medicine (IOM), low participation in new clinical trials and research were discussed between industry professionals. One viewpoint states mistrust of clinical trials, science in general and the motives of the industry...
The National Center for Advancing Translational Sciences is a research center focused on expediting the process from breakthroughs in the lab to the clinic. Opening of the center has been delayed by funding from the government, with no clear decision in site. The...
